Back to Search
Start Over
Major Clinical Study Using Semler's QuantaFlo(r) for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
- Source :
- Plus Company Updates. December 17, 2022
- Publication Year :
- 2022
-
Abstract
- SANTA CLARA: Semler Scientific, Inc has issued the following news release: Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.731219639